Загрузка...
Controversies about extended-spectrum and AmpC beta-lactamases.
Many clinical laboratories have problems detecting extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamases. Confusion exists about the importance of these resistance mechanisms, optimal test methods, and appropriate reporting conventions. Failure to detect these enzymes h...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Centers for Disease Control and Prevention
2001
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2631719/ https://ncbi.nlm.nih.gov/pubmed/11294735 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|